Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-519492-25-01Phase 4Completed
Phase 4, randomised trial of glycerol in low anterior resection syndrome (LARS) (2 arms), sponsored by Central Denmark Region. Primary endpoint: Change in main symptom score (MYMOP). Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-519492-25-01.